{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:25:30Z","timestamp":1789179930647,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1124\/jpet.119.256446","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T22:05:21Z","timestamp":1552601121000},"page":"814-822","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Gellan Gum Based Sol-to-Gel Transforming System of Natamycin Transfersomes Improves Topical Ocular Delivery"],"prefix":"10.1016","volume":"370","author":[{"given":"Karthik Yadav","family":"Janga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya","family":"Tatke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendar","family":"Dudhipala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Prachetan","family":"Balguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Moustafa","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa Nabih","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Jablonski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyajit","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.119.256446_bib1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","article-title":"Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment","volume":"513","author":"Abdelbary","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.256446_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2012.04.063","article-title":"Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen\u2019s egg chorioallantoic membrane and excised bovine cornea models","volume":"432","author":"Abdelkader","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.256446_bib3","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/jps.22422","article-title":"Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery","volume":"100","author":"Abdelkader","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.119.256446_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/10717544.2016.1256000","article-title":"Diclofenac sodium ion exchange resin complex loaded melt cast films for sustained release ocular delivery","volume":"24","author":"Adelli","year":"2017","journal-title":"Drug Deliv"},{"key":"10.1124\/jpet.119.256446_bib5","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3109\/10717544.2014.943336","article-title":"Liposomes in topical ophthalmic drug delivery: an update","volume":"23","author":"Agarwal","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1124\/jpet.119.256446_bib6","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.sjopt.2014.02.009","article-title":"Nanocarriers of nanotechnology in retinal diseases","volume":"28","author":"Al-Halafi","year":"2014","journal-title":"Saudi J Ophthalmol"},{"key":"10.1124\/jpet.119.256446_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1586\/17512433.1.1.145","article-title":"Challenges and solutions in topical ocular drug-delivery systems","volume":"1","author":"Ali","year":"2008","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/jpet.119.256446_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijpharm.2015.03.033","article-title":"Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam","volume":"485","author":"Al-Mahallawi","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.256446_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejpb.2016.10.015","article-title":"Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues","volume":"109","author":"Balguri","year":"2016","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1124\/jpet.119.256446_bib10","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1016\/j.xphs.2017.07.017","article-title":"Melt-cast noninvasive ocular inserts for posterior segment drug delivery","volume":"106","author":"Balguri","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.119.256446_bib11","first-page":"238","article-title":"Ocular drug delivery; impact of in vitro cell culture models","volume":"4","author":"Barar","year":"2009","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1124\/jpet.119.256446_bib12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2012.04.060","article-title":"Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies","volume":"432","author":"Bhatta","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.256446_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.colsurfb.2016.03.061","article-title":"The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system","volume":"143","author":"Chen","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1124\/jpet.119.256446_bib14","first-page":"1921","article-title":"Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation","volume":"8","author":"Dai","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"10.1124\/jpet.119.256446_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0008-6215(00)80832-0","article-title":"Studies on dilute solutions and dispersion of the polysaccharide from Xanthomonas campestris NNRL B-1459","volume":"13","author":"Dintzis","year":"1970","journal-title":"Carbohydr Res"},{"key":"10.1124\/jpet.119.256446_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/10837450.2015.1091839","article-title":"Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery","volume":"21","author":"Duxfield","year":"2016","journal-title":"Pharm Dev Technol"},{"key":"10.1124\/jpet.119.256446_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.15171\/bi.2015.31","article-title":"Hydrogels for ocular drug delivery and tissue engineering","volume":"5","author":"Fathi","year":"2015","journal-title":"Bioimpacts"},{"key":"10.1124\/jpet.119.256446_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1567201813666160520114436","article-title":"Ethosomes and transfersomes: principles, perspectives and practices","volume":"14","author":"Garg","year":"2017","journal-title":"Curr Drug Deliv"},{"key":"10.1124\/jpet.119.256446_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.addr.2017.09.008","article-title":"Overcoming ocular drug delivery barriers through the use of physical forces","volume":"126","author":"Huang","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.119.256446_bib20","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/jps.23417","article-title":"Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release","volume":"102","author":"Ibrahim","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.119.256446_bib21","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1016\/j.xphs.2016.09.019","article-title":"Stability and ocular pharmacokinetics of celecoxib-loaded nanoparticles topical ophthalmic formulations","volume":"105","author":"Ibrahim","year":"2016","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.119.256446_bib22","doi-asserted-by":"crossref","first-page":"44229","DOI":"10.1038\/srep44229","article-title":"Creation of nano eye-drops and effective drug delivery to the interior of the eye","volume":"7","author":"Ikuta","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/jpet.119.256446_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15406\/japlr.2016.02.00022","article-title":"Newer trends in in situ gelling systems for controlled ocular drug delivery","volume":"2","author":"Jain","year":"2016","journal-title":"J Anal Pharm Res"},{"key":"10.1124\/jpet.119.256446_bib24","doi-asserted-by":"crossref","first-page":"S1039","DOI":"10.1080\/21691401.2018.1443117","article-title":"Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation","volume":"46","author":"Janga","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"10.1124\/jpet.119.256446_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/02652049509010292","article-title":"Factors affecting microencapsulation of drugs in liposomes","volume":"12","author":"Kulkarni","year":"1995","journal-title":"J Microencapsul"},{"key":"10.1124\/jpet.119.256446_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/2231-4040.107495","article-title":"Nanoparticles laden in situ gelling system for ocular drug targeting","volume":"4","author":"Kumar","year":"2013","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1124\/jpet.119.256446_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/2230-973X.100036","article-title":"Stimuli sensitive hydrogels for ophthalmic drug delivery: a review","volume":"2","author":"Kushwaha","year":"2012","journal-title":"Int J Pharm Investig"},{"key":"10.1124\/jpet.119.256446_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2008.08.013","article-title":"Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate","volume":"364","author":"Liu","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.256446_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11095-008-9729-6","article-title":"Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: a natural bioflavonoid","volume":"26","author":"Majumdar","year":"2009","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.119.256446_bib31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejps.2017.04.013","article-title":"Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide","volume":"104","author":"Morsi","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/jpet.119.256446_bib32","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1021\/mp500332m","article-title":"On the barrier properties of the cornea: a microscopy study of the penetration of fluorescently labeled nanoparticles, polymers, and sodium fluorescein","volume":"11","author":"Mun","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1124\/jpet.119.256446_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i1.30","article-title":"In situ gelling polymers in ocular drug delivery systems: a review","volume":"26","author":"Mundada","year":"2009","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"10.1124\/jpet.119.256446_bib34","first-page":"821","article-title":"A novel in situ gel for sustained ophthalmic delivery of ciprofloxacin hydrochloride and dexamethasone-design and characterization","volume":"4","author":"Nagesh","year":"2012","journal-title":"Der Pharmacia Lettre"},{"key":"10.1124\/jpet.119.256446_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/2230-973X.176488","article-title":"Formulation and evaluation of voriconazole ophthalmic solid lipid nanoparticles in situ gel","volume":"6","author":"Pandurangan","year":"2016","journal-title":"Int J Pharm Investig"},{"key":"10.1124\/jpet.119.256446_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jddst.2017.03.005","article-title":"Formulation development and evaluation of natamycin niosomal in-situ gel for ophthalmic drug delivery","volume":"39","author":"Paradkar","year":"2017","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1124\/jpet.119.256446_bib37","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","article-title":"Ocular drug delivery systems: an overview","volume":"2","author":"Patel","year":"2013","journal-title":"World J Pharmacol"},{"key":"10.1124\/jpet.119.256446_bib38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/03639045.2017.1402918","article-title":"Development of zolmitriptan transfersomes by Box-Behnken design for nasal delivery: in vitro and in vivo evaluation","volume":"44","author":"Pitta","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1124\/jpet.119.256446_bib39","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/ard.2006.065128","article-title":"Efficacy and safety of epicutaneous ketoprofen in transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial","volume":"66","author":"Rother","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1124\/jpet.119.256446_bib40","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1167\/iovs.13-13707","article-title":"Drug and gene delivery to the back of the eye: from bench to bedside","volume":"55","author":"Rowe-Rendleman","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.119.256446_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2011.03.042","article-title":"Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release","volume":"411","author":"Rupenthal","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1124\/jpet.119.256446_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/08982104.2013.801489","article-title":"Transfersomal lyophilized gel of buspirone HCl: formulation, evaluation and statistical optimization","volume":"23","author":"Shamma","year":"2013","journal-title":"J Liposome Res"},{"key":"10.1124\/jpet.119.256446_bib43","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1872211309666150724101227","article-title":"In situ gelling ophthalmic drug delivery system: an overview and its applications","volume":"9","author":"Sheshala","year":"2015","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"10.1124\/jpet.119.256446_bib44","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.drudis.2016.03.013","article-title":"Bilosomes in the context of oral immunization: development, challenges and opportunities","volume":"21","author":"Shukla","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1124\/jpet.119.256446_bib45","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/ics.12125","article-title":"Texture analysis of cosmetic\/pharmaceutical raw materials and formulations","volume":"36","author":"Tai","year":"2014","journal-title":"Int J Cosmet Sci"},{"key":"10.1124\/jpet.119.256446_bib46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00003226-200005000-00010","article-title":"Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania","volume":"19","author":"Tanure","year":"2000","journal-title":"Cornea"},{"key":"10.1124\/jpet.119.256446_bib47","first-page":"134","article-title":"Analytical method development and validation of natamycin in eye drop by RP-HPLC","volume":"6","author":"Thangabalan","year":"2013","journal-title":"Asian J Pharm Clin Res"},{"key":"10.1124\/jpet.119.256446_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/JAMPS\/2017\/33924","article-title":"Quality control tests for ophthalmic pharmaceuticals: pharmacopoeial standards and specifications","volume":"14","author":"Uddin","year":"2017","journal-title":"J Adv Med Pharm Sci"},{"key":"10.1124\/jpet.119.256446_bib49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/jpet.119.256446_bib50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0378-5173(93)90115-V","article-title":"A novel approach to the preparation of injectable emulsions by a spontaneous emulsification process","volume":"89","author":"Yu","year":"1993","journal-title":"Int J Pharm"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524260535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.119.256446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:54:01Z","timestamp":1739994841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524260535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0022356524260535"],"URL":"https:\/\/doi.org\/10.1124\/jpet.119.256446","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gellan Gum Based Sol-to-Gel Transforming System of Natamycin Transfersomes Improves Topical Ocular Delivery","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.119.256446","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}